Metabolic Barriers to T Cell Function in Tumors
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
The metabolic programs that drive T cell functions are exquisitely sensitive to cell intrinsic and extrinsic factors, allowing T cells to respond in a fine-tuned manner to a variety of immune challenges and conditions. However, many of the factors essential for effector T cell function are perturbed in the tumor microenvironment, where oncogenic mutations drive unrestrained cancer cell growth that leads to excess nutrient consumption, excess waste excretion, and insufficient oxygen delivery. This imposes metabolic constraints on infiltrating cells that result in dysfunction and loss of potential antitumor activity in both naturally occurring as well as tailored T cells introduced as part of immunotherapy. In this review, we highlight the metabolic properties that characterize tumor-infiltrating T cells, the barriers within the metabolic landscape of the tumor microenvironment, and the opportunities and challenges they present in development of new cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is known that mesothelioma cells increase the expression of L-type Amino acid Transporter 1 (LAT1), depriving T-cells of amino acids, such as arginine and tryptophan, which are essential for T-cell function and proliferation [121].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mesothelioma cells could also inhibit T-cell glycolysis and functions, increasing the levels of indoleamine-pyrrole 2,3-dioxygenase (IDO), which degrades tryptophan into kynurenine, a well-known immunosuppression factor [121,123,124].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the mesothelioma microenvironment, the availability of glucose is critical, and competition for this molecule impacts on T-cell function and the recruitment of immune infiltrating cells, promoting angiogenesis [119,120,121,122].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“required for maintaining the TCA cycle as well as a vital source for lipid synthesis through reductive carboxylation in hypoxic cancer cells (1) and Teff cells (2).”
BackgroundCommensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549 · cited 1×
“Both in vitro and in vivo studies in the gut suggest short chain FAs can induce Treg cell differentiation (67, 68), although this may be through changes in G protein–coupled receptor-mediated signaling rather than direct use as a metabolic fuel.”
BackgroundThe Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · cited 1×
“Both in vitro and in vivo studies in the gut suggest short chain FAs can induce Treg cell differentiation (67, 68), although this may be through changes in G protein–coupled receptor-mediated signaling rather than direct use as a metabolic fuel.”
BackgroundImmune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229 · cited 1×
“Consider PD-1 blockade, which has yielded promising results in many cancer patients, but not so in a sizeable population of patients (83).”
BackgroundKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · cited 1×
“Increased HIF1a activity promotes aerobic glycolysis and reduces OXPHOS by upregulating pyruvate dehydrogenase kinase (PDK1) and lactate dehydrogenase A (26, 27), effectively shunting pyruvate away”
BackgroundMetabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172 · cited 1×
“Hypoxia and upregulation of HIF1a in tumors are both associated with poor clinical outcomes in cancer patients (69).”
BackgroundFunctional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · cited 1×
“Additionally, lactate has been shown to stabilize HIF1a in macrophages (74), and can be predicted to have similar effects in T cells.”
BackgroundIschaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
Chouchani, E. T., Pell, V. R., Gaude, E., Aksentijević, D., Sundier, S. Y., Robb, E. L., Logan, A., Nadtochiy, S. M., Ord, E. N. J., Smith, A. C., et al. (2014) · Nature · doi:10.1038/nature13909 · Cited by 2,907
Understanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267 · cited 1×
“Increased HIF1a activity promotes aerobic glycolysis and reduces OXPHOS by upregulating pyruvate dehydrogenase kinase (PDK1) and lactate dehydrogenase A (26, 27), effectively shunting pyruvate away”
BackgroundPosttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204 · cited 1×
“IFN-g translation can also be suppressed given the regulatory role of GAPDH in this process (12).”
BackgroundThe transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140 · cited 4×
“Teff cell activation, proliferation, and cytokine production (3, 5, 17).”
BackgroundInfluentialMichalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003613 · Cited by 2,091 · cited 5×
“cells induced in culture as well as in in vivo model of inflammatory disease, and glucose-deficient conditions instead promote Treg cell induction and suppressive activity in vitro (13, 14, 28).”
BackgroundInfluentialSelf-citationLDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.011 · Cited by 2,039 · cited 2×
“Although increased exposure to lactate can inhibit Teff cells (21), lactate can be efficiently oxidized by Treg cells (22).”
BackgroundInhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946 · cited 1×
“Treatment with excess lactic acid inhibits human CD8 T cell activation, proliferation, and effector functions in vitro (71), whereas neutralization of TME acidosis by bicarbonate therapy improves response rates in checkpoint blockade as well as adoptive cell therapy in murine models (72).”
BackgroundCTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931 · cited 3×
“PD-1 ligation leads to reduction in PI3K/Akt/ mTOR pathway activity (6) with associated reduction in c-Myc expression (78, 79).”
BackgroundShi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Geiger, R., Rieckmann, J. C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.031 · Cited by 1,775
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
mTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 1×
“Accordingly, mTOR inhibition in Teff cells via rapamycin treatment promotes formation of Tmem cells (42, 43), an effect that is similarly induced with AMPK activation via”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 2×
“Accordingly, mTOR inhibition in Teff cells via rapamycin treatment promotes formation of Tmem cells (42, 43), an effect that is similarly induced with AMPK activation via”
BackgroundMitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development
van der Windt, G. J. W., Everts, B., Chang, C.-H., Curtis, J. D., Freitas, T. C., Amiel, E., Pearce, E. J., & Pearce, E. L. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.007 · Cited by 1,540 · cited 1×
“More specifically, there is an increase in mitochondrial mass with a concomitant increase in spare respiratory capacity (40) that is proposed to allow rapid ATP production following restimulation.”
BackgroundThe CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475 · cited 15×
“Likewise, deletion of the large neutral amino acid transporter SLC7a5 (LAT1) prevents mTORC1 activation, thus impairing induction of Glut1 expression and aerobic glycolysis in stimulated T cells ex vivo and in vivo (18).”
BackgroundInfluentialSelf-citationPhosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462 · cited 5×
“antitumor function of T cells (49, 50) and accumulation of lactate can impair Teff cells (21) while promoting Treg cells (52) ex vivo.”
BackgroundInfluentialSelf-citationMitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Buck, M. D., O’Sullivan, D., Klein Geltink, R. I., Curtis, J. D., Chang, C.-H., Sanin, D. E., Qiu, J., Kretz, O., Braas, D., van der Windt, G. J. W., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.035 · Cited by 1,443
Sena, L. A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D. A., Wang, C.-R., Schumacker, P. T., Licht, J. D., Perlman, H., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.020 · Cited by 1,338
The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil-de-Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,246 · cited 2×
“Within tumors, this effectively renders Treg cells less glucose dependent and also better equipped to consume lactate as a mitochondrial fuel (22).”
BackgroundPatsoukis, N., Bardhan, K., Chatterjee, P., Sari, D., Liu, B., Bell, L. N., Karoly, E. D., Freeman, G. J., Petkova, V., Seth, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms7692 · Cited by 1,202 · cited 10×
“This can impair metabolic reprogramming such as the upregulation of glycolysis (7) and glutaminolysis (6) that is critical to effective antitumor activity in TILs.”
BackgroundInfluentialMacintyre, A. N., Gerriets, V. A., Nichols, A. G., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.004 · Cited by 1,127 · cited 16×
“cells induced in culture as well as in in vivo model of inflammatory disease, and glucose-deficient conditions instead promote Treg cell induction and suppressive activity in vitro (13, 14, 28).”
BackgroundInfluentialSelf-citationIndoleamine 2,3 dioxygenase and metabolic control of immune responses
Munn, D. H., & Mellor, A. L. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.001 · Cited by 1,037
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Sukumar, M., Liu, J., Ji, Y., Subramanian, M., Crompton, J. G., Yu, Z., Roychoudhuri, R., Palmer, D. C., Muranski, P., Karoly, E. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69589 · Cited by 952 · cited 1×
“Conversely, T cell metabolism can be modulated to favor generation of Tmem cells that may enhance adoptive T cell therapy and immunotherapy (87).”
BackgroundSinclair, L. V., Rolf, J., Emslie, E., Shi, Y.-B., Taylor, P. M., & Cantrell, D. A. (2013) · Nature Immunology · doi:10.1038/ni.2556 · Cited by 930 · cited 1×
“Likewise, deletion of the large neutral amino acid transporter SLC7a5 (LAT1) prevents mTORC1 activation, thus impairing induction of Glut1 expression and aerobic glycolysis in stimulated T cells ex vivo and in vivo (18).”
BackgroundNakaya, M., Xiao, Y., Zhou, X., Chang, J.-H., Chang, M., Cheng, X., Blonska, M., Lin, X., & Sun, S.-C. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.007 · Cited by 866 · cited 1×
“Further, genetic deletion of ASCT2 specifically reduces Th1 and Th17 numbers in vivo without affecting the generation of Th2 and Treg cells (19), highlighting the dif-”
BackgroundJacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850 · cited 15×
“Likewise, deletion of the large neutral amino acid transporter SLC7a5 (LAT1) prevents mTORC1 activation, thus impairing induction of Glut1 expression and aerobic glycolysis in stimulated T cells ex vivo and in vivo (18).”
BackgroundInfluentialSelf-citationScharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R. E., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.009 · Cited by 848 · cited 1×
“Additionally, mitochondria have been reported to be depleted from T cells in melanoma models (47).”
BackgroundCarr, E. L., Kelman, A., Wu, G. S., Gopaul, R., Senkevitch, E., Aghvanyan, A., Turay, A. M., & Frauwirth, K. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903586 · Cited by 830 · cited 3×
“Teff cell activation, proliferation, and cytokine production (3, 5, 17).”
BackgroundO’Sullivan, D., van der Windt, G. J. W., Huang, S. C.-C., Curtis, J. D., Chang, C.-H., Buck, M. D., Qiu, J., Smith, A. M., Lam, W. Y., DiPlato, L. M., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.005 · Cited by 790 · cited 4×
“FAO in Tmem cells is proposed to be largely fueled by de novo FA synthesis instead of by imported exogenous FAs (41).”
BackgroundInfluentialAerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
Peng, M., Yin, N., Chhangawala, S., Xu, K., Leslie, C. S., & Li, M. O. (2016) · Science · doi:10.1126/science.aaf6284 · Cited by 787 · cited 1×
“Additionally, generation of acetyl-CoA via glucose metabolism can influence histone acetylation to epigenetically regulate cytokine transcription (56).”
BackgroundA mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells
Barsoum, I. B., Smallwood, C. A., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0992 · Cited by 767 · cited 1×
“is frequently expressed in tumors and exploited to reduce inflammation and antitumor immunity (8, 9).”
BackgroundIFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
Abiko, K., Matsumura, N., Hamanishi, J., Horikawa, N., Murakami, R., Yamaguchi, K., Yoshioka, Y., Baba, T., Konishi, I., & Mandai, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.101 · Cited by 725 · cited 1×
“is frequently expressed in tumors and exploited to reduce inflammation and antitumor immunity (8, 9).”
BackgroundScharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R. E., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.009 · Cited by 706
Arginase: an emerging key player in the mammalian immune system
Munder, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00291.x · Cited by 694 · cited 1×
“Arginine is critical to the urea cycle and polyamine synthesis pathways that are essential for supporting a variety of biochemical and potential signaling functions (58).”
BackgroundHypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen
Doedens, A. L., Phan, A. T., Stradner, M. H., Fujimoto, J. K., Nguyen, J. V., Yang, E., Johnson, R. S., & Goldrath, A. W. (2013) · Nature Immunology · doi:10.1038/ni.2714 · Cited by 660 · cited 13×
“E-mail address: jeff.rathmell@vanderbilt.edu Abbreviations used in this article: AMPK, AMP-activated protein kinase; FA, fatty acid; FAO, FA oxidation; HIF1a, hypoxia inducible factor 1a; mTOR, mechanistic target of rapamycin; mTORC1, mTOR complex 1; OXPHOS, oxidative phosphorylation; ROS, reactive oxygen species; Tef…”
BackgroundInfluentialCalcinotto, A., Filipazzi, P., Grioni, M., Iero, M., De Milito, A., Ricupito, A., Cova, A., Canese, R., Jachetti, E., Rossetti, M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1272 · Cited by 640 · cited 1×
“Moreover, extracellular acidification has been shown to induce mitochondrial remodeling leading to metabolic adaptation (76, 77).”
BackgroundFinlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112607 · Cited by 596 · cited 1×
“Activation of mTOR promotes glycolysis through several mechanisms, including through the upregulation of the major regulators c-Myc and hypoxia inducible factor 1a (HIF1a) (3, 5, 11, 14, 23, 24).”
BackgroundNeutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Pilon-Thomas, S., Kodumudi, K. N., El-Kenawi, A. E., Russell, S., Weber, A. M., Luddy, K., Damaghi, M., Wojtkowiak, J. W., Mulé, J. J., Ibrahim-Hashim, A., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1743 · Cited by 593 · cited 2×
“Acid-sensing receptors may contribute to downregulation of Myc expression (75) as well as inhibition of glycolysis in these cells (72).”
BackgroundSelective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade
Blackburn, S. D., Shin, H., Freeman, G. J., & Wherry, E. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801497105 · Cited by 579 · cited 1×
“aerobic glycolysis through increased expression of Glut1 and glycolytic enzymes, with subsequent enhancement in Teff cell activation and proliferation (80).”
BackgroundFoxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression
Gerriets, V. A., Kishton, R. J., Johnson, M. O., Cohen, S., Siska, P. J., Nichols, A. G., Warmoes, M. O., de Cubas, A. A., MacIver, N. J., Locasale, J. W., et al. (2016) · Nature Immunology · doi:10.1038/ni.3577 · Cited by 539
Self-citationCD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability
van der Windt, G. J. W., O’Sullivan, D., Everts, B., Huang, S. C.-C., Buck, M. D., Curtis, J. D., Chang, C.-H., Smith, A. M., Ai, T., Faubert, B., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221740110 · Cited by 523 · cited 1×
“is encoded in part by “priming” of the metabolic program (38, 39).”
BackgroundRapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch
Gubser, P. M., Bantug, G. R., Razik, L., Fischer, M., Dimeloe, S., Hoenger, G., Durovic, B., Jauch, A., & Hess, C. (2013) · Nature Immunology · doi:10.1038/ni.2687 · Cited by 493 · cited 1×
“is encoded in part by “priming” of the metabolic program (38, 39).”
BackgroundNitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities
Mocellin, S., Bronte, V., & Nitti, D. (2007) · Medicinal Research Reviews · doi:10.1002/med.20092 · Cited by 478 · cited 1×
“expressed in a variety of cancer cells as well as in tumorassociated alternatively activated M2 macrophages that can promote tumor progression (59).”
BackgroundChamoto, K., Chowdhury, P. S., Kumar, A., Sonomura, K., Matsuda, F., Fagarasan, S., & Honjo, T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620433114 · Cited by 413 · cited 1×
“In settings where TIL mitochondrial content has been normal (46, 48), mitochondrial structure and function were nevertheless altered, suggesting a general”
BackgroundControl of PI(3) kinase in Treg cells maintains homeostasis and lineage stability
Huynh, A., DuPage, M., Priyadharshini, B., Sage, P. T., Quiros, J., Borges, C. M., Townamchai, N., Gerriets, V. A., Rathmell, J. C., Sharpe, A. H., et al. (2015) · Nature Immunology · doi:10.1038/ni.3077 · Cited by 411
Self-citationSiska, P. J., Beckermann, K. E., Mason, F. M., Andrejeva, G., Greenplate, A. R., Sendor, A. B., Chiang, Y.-C. J., Corona, A. L., Gemta, L. F., Vincent, B. G., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93411 · Cited by 389 · cited 6×
“activation of Tmem cells from patient samples of clear cell renal cell carcinoma (46).”
BackgroundInfluentialSelf-citationCham, C. M., Driessens, G., O'Keefe, J. P., & Gajewski, T. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200838289 · Cited by 388 · cited 1×
“TCR signaling, proliferation, and cytokine production (10, 11, 13, 55).”
BackgroundSimilarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 373 · cited 6×
“To maintain aerobic glycolysis in Teff cells, pyruvate is shunted away from the TCA cycle and toward lactate production despite sufficient oxygen levels to support respiration (2).”
BackgroundInfluentialSelf-citationTreg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses
Shrestha, S., Yang, K., Guy, C., Vogel, P., Neale, G., & Chi, H. (2015) · Nature Immunology · doi:10.1038/ni.3076 · Cited by 364
Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development
Wang, Q., Hardie, R., Hoy, A. J., van Geldermalsen, M., Gao, D., Fazli, L., Sadowski, M. C., Balaban, S., Schreuder, M., Nagarajah, R., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4518 · Cited by 338 · cited 1×
“The major glutamine transporter SLC1a5 (ASCT2) is overexpressed in several types of cancer, including melanoma and prostate cancer (57).”
BackgroundDillon, B. J., Prieto, V. G., Curley, S. A., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2004) · Cancer · doi:10.1002/cncr.20057 · Cited by 314
An Enigmatic Tail of CD28 Signaling
Boomer, J. S., & Green, J. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002436 · Cited by 283 · cited 1×
“Costimulation both augments TCR signals and stimulates PI3K/Akt/mTOR complex 1 (mTORC1) pathway activity (4).”
Backgroundl -Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells
Fletcher, M., Ramirez, M. E., Sierra, R. A., Raber, P., Thevenot, P., Al-Khami, A. A., Sanchez-Pino, D., Hernandez, C., Wyczechowska, D. D., Ochoa, A. C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1491 · Cited by 281 · cited 1×
“T cells are also highly dependent on arginine, and this amino acid can rapidly become limiting for proliferation and function (61, 62).”
BackgroundAnergic T Cells Are Metabolically Anergic
Zheng, Y., Delgoffe, G. M., Meyer, C. F., Chan, W., & Powell, J. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803510 · Cited by 279 · cited 1×
“TCR signaling, proliferation, and cytokine production (10, 11, 13, 55).”
BackgroundBeier, U. H., Angelin, A., Akimova, T., Wang, L., Liu, Y., Xiao, H., Koike, M. A., Hancock, S. A., Bhatti, T. R., Han, R., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-268409 · Cited by 275 · cited 1×
“antitumor function of T cells (49, 50) and accumulation of lactate can impair Teff cells (21) while promoting Treg cells (52) ex vivo.”
BackgroundMonocarboxylate transporter MCT1 is a target for immunosuppression
Murray, C. M., Hutchinson, R., Bantick, J. R., Belfield, G. P., Benjamin, A. D., Brazma, D., Bundick, R. V., Cook, I. D., Craggs, R. I., Edwards, S., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio744 · Cited by 248 · cited 1×
“Additionally, expression of the monocarboxylate lactate transporters MCT1 and MCT4 are increased (20) to facilitate removal of lactate produced in aerobic glycolysis.”
BackgroundAMPK α1: A glucose sensor that controls CD 8 T ‐cell memory
Rolf, J., Zarrouk, M., Finlay, D. K., Foretz, M., Viollet, B., & Cantrell, D. A. (2013) · European Journal of Immunology · doi:10.1002/eji.201243008 · Cited by 245
CAR T‐cell therapy of solid tumors
Yong, C. S. M., Dardalhon, V., Devaud, C., Taylor, N., Darcy, P. K., & Kershaw, M. H. (2017) · Immunology & Cell Biology · doi:10.1038/icb.2016.128 · Cited by 220
Inaba, T., Ino, K., Kajiyama, H., Yamamoto, E., Shibata, K., Nawa, A., Nagasaka, T., Akimoto, H., Takikawa, O., & Kikkawa, F. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.07.015 · Cited by 216 · cited 1×
“high levels found in melanoma (63), pancreatic ductal adenocarcinoma (64), and ovarian cancer (65).”
BackgroundFoxp3 drives oxidative phosphorylation and protection from lipotoxicity
Howie, D., Cobbold, S. P., Adams, E., Ten Bokum, A., Necula, A. S., Zhang, W., Huang, H., Roberts, D. J., Thomas, B., Hester, S. S., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89160 · Cited by 216
The Genomic Analysis of Lactic Acidosis and Acidosis Response in Human Cancers
Chen, J. L.-Y., Lucas, J. E., Schroeder, T., Mori, S., Wu, J., Nevins, J., Dewhirst, M., West, M., & Chi, J.-T. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000293 · Cited by 213 · cited 1×
“suppression of the PI3K/Akt/mTORC1 pathway and glycolysis in culture (73).”
BackgroundPhan, A. T., Doedens, A. L., Palazon, A., Tyrakis, P. A., Cheung, K. P., Johnson, R. S., & Goldrath, A. W. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.017 · Cited by 208 · cited 1×
“At the same time, glycolysis remains required for CD4 Tmem cell formation and to promote increased Tmem cell numbers as shown by treatment with the glycolytic inhibitor 2-deoxyglucose in culture (45).”
BackgroundAcidosis overrides oxygen deprivation to maintain mitochondrial function and cell survival
Khacho, M., Tarabay, M., Patten, D., Khacho, P., MacLaurin, J. G., Guadagno, J., Bergeron, R., Cregan, S. P., Harper, M.-E., Park, D. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4550 · Cited by 192 · cited 1×
“Moreover, extracellular acidification has been shown to induce mitochondrial remodeling leading to metabolic adaptation (76, 77).”
BackgroundPatsoukis, N., Li, L., Sari, D., Petkova, V., & Boussiotis, V. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00319-13 · Cited by 187
Brody, J. R., Costantino, C. L., Berger, A. C., Sato, T., Lisanti, M. P., Yeo, C. J., Emmons, R. V., & Witkiewicz, A. K. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8745 · Cited by 174 · cited 1×
“high levels found in melanoma (63), pancreatic ductal adenocarcinoma (64), and ovarian cancer (65).”
BackgroundO'Connor, J. P. B., Boult, J. K. R., Jamin, Y., Babur, M., Finegan, K. G., Williams, K. J., Little, R. A., Jackson, A., Parker, G. J. M., Reynolds, A. R., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2062 · Cited by 161 · cited 1×
“parameters (84), as well as oxygen-enriched magnetic resonance imaging for tumor hypoxia measurements in situ as shown in preclinical cancer models (85).”
BackgroundSiska, P. J., van der Windt, G. J. W., Kishton, R. J., Cohen, S., Eisner, W., MacIver, N. J., Kater, A. P., Weinberg, J. B., & Rathmell, J. C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502464 · Cited by 151
Self-citationTSC1 regulates the balance between effector and regulatory T cells
Park, Y., Jin, H.-S., Lopez, J., Elly, C., Kim, G., Murai, M., Kronenberg, M., & Liu, Y.-C. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69751 · Cited by 143
Shimatani, K., Nakashima, Y., Hattori, M., Hamazaki, Y., & Minato, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908805106 · Cited by 132 · cited 1×
“PD-1 ligation leads to reduction in PI3K/Akt/ mTOR pathway activity (6) with associated reduction in c-Myc expression (78, 79).”
BackgroundGenotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target
Witkiewicz, A. K., Costantino, C. L., Metz, R., Muller, A. J., Prendergast, G. C., Yeo, C. J., & Brody, J. R. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2008.12.018 · Cited by 127
PD-1 regulates extrathymic regulatory T-cell differentiation
Chen, X., Fosco, D., Kline, D. E., Meng, L., Nishi, S., Savage, P. A., & Kline, J. (2014) · European Journal of Immunology · doi:10.1002/eji.201344423 · Cited by 107 · cited 1×
“Additionally, PD-1 ligation has been shown to promote FAO (7), thereby promoting Treg cell differentiation and suppressive activity (81) as well as Tmem cell formation (82) as shown by murine adoptive transfer studies.”
BackgroundOttensmeier, C. H., Perry, K. L., Harden, E. L., Stasakova, J., Jenei, V., Fleming, J., Wood, O., Woo, J., Woelk, C. H., Thomas, G. J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3121 · Cited by 99 · cited 1×
“Accordingly, overexpression of Glut1 in a tumor correlates with low CD8 T cell infiltration (53) and poor prognosis in certain cancers (54).”
Backgroundc-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells
Chou, C., Pinto, A. K., Curtis, J. D., Persaud, S. P., Cella, M., Lin, C.-C., Edelson, B. T., Allen, P. M., Colonna, M., Pearce, E. L., et al. (2014) · Nature Immunology · doi:10.1038/ni.2943 · Cited by 95
Basu, S., Hubbard, B., & Shevach, E. M. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ab0514-273rr · Cited by 64 · cited 1×
“However, Treg cells retain the capacity to divide rapidly in response to homeostatic signals as well as in response to inflammatory cues such as TLR (33).”
BackgroundProgrammed Death-1 Shapes Memory Phenotype CD8 T Cell Subsets in a Cell-Intrinsic Manner
Charlton, J. J., Chatzidakis, I., Tsoukatou, D., Boumpas, D. T., Garinis, G. A., & Mamalaki, C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201617 · Cited by 58
Li, Z., Dong, L., Dean, E. A., & Yang, L. V. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020236 · Cited by 53 · cited 1×
“Acid-sensing receptors may contribute to downregulation of Myc expression (75) as well as inhibition of glycolysis in these cells (72).”
BackgroundDavis-Yadley, A. H., Abbott, A. M., Pimiento, J. M., Chen, D., & Malafa, M. P. (2015) · Pancreas · doi:10.1097/mpa.0000000000000580 · Cited by 40 · cited 1×
“Accordingly, overexpression of Glut1 in a tumor correlates with low CD8 T cell infiltration (53) and poor prognosis in certain cancers (54).”
BackgroundLin, G., & Chung, Y. (2014) · BioMed Research International · doi:10.1155/2014/625095 · Cited by 33 · cited 1×
“parameters (84), as well as oxygen-enriched magnetic resonance imaging for tumor hypoxia measurements in situ as shown in preclinical cancer models (85).”
BackgroundShi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G. A. M., Green, D. R., & Chi, H. (2011) · The Journal of Cell Biology · doi:10.1083/jcb1941oia1 · Cited by 1
Research works printed but not linked: 3
- Michalek RD Gerriets VA Jacobs SR Macintyre AN MacIver NJ Mason EF Sullivan SA Nichols AG Rathmell JC 2011 Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets The Journal of Immunology 186 3299 3303 21317389 PMC3198034
- Gerriets VA Kishton RJ Johnson MO Cohen S Siska PJ Nichols AG Warmoes MO de Cubas AA MacIver NJ Locasale JW Turka LA Wells AD Rathmell JC 2016 Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression Nat Immunol 17 1459 1466 27695003 PMC5215903
- Frauwirth KA Riley JL Harris MH Parry RV Rathmell JC Plas DR Elstrom RL June CH Thompson CB 2002 The CD28 Signaling Pathway Regulates Glucose Metabolism Immunity 16 769 777 12121659
Cited by
Top 10 Challenges in Cancer Immunotherapy
Hegde, P. S., & Chen, D. S. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.011 · Cited by 2,238
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
Ringel, A. E., Drijvers, J. M., Baker, G. J., Catozzi, A., García-Cañaveras, J. C., Gassaway, B. M., Miller, B. C., Juneja, V. R., Nguyen, T. H., Joshi, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.009 · Cited by 780
“Tumor cell metabolism is known to alter many aspects of the local metabolic landscape in ways that inhibit anti-tumor immunity (Sugiura and Rathmell, 2018).”
BackgroundMetabolites and the Tumour Microenvironment: From Cellular Mechanisms to Systemic Metabolism
Elia, I., & Haigis, M. C. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00317-z · Cited by 651
Metabolic barriers to cancer immunotherapy
DePeaux, K., & Delgoffe, G. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00541-y · Cited by 597
Metabolic and epigenetic regulation of T-cell exhaustion
Franco, F., Jaccard, A., Romero, P., Yu, Y.-R., & Ho, P.-C. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00280-9 · Cited by 455
Metadata
- Authors
- Sugiura, A., & Rathmell, J. C.
- Affiliations
- Vanderbilt-Ingram Cancer Center (US)
- Corresponding author
- Rathmell, Jeffrey C
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01
- Volume
- 200
- Issue
- 2
- Pages
- 400-407
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC5777533
- OpenAlex
- W2784164696
- Cited by
- 208
- References
- 89
- Citations by year
- 2026: 22 · 2025: 18 · 2024: 15 · 2023: 30 · 2022: 35 · 2021: 32 · 2020: 29 · 2019: 18 · 2018: 9
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (T32GM007347)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK105550)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- T cell metabolism, tumor microenvironment, tumor-infiltrating T cells, T cell dysfunction, cancer immunotherapy, nutrient consumption, oxygen delivery, oncogenic mutations, cancer therapeutics
- MeSH terms
- Animals, Energy Metabolism, Humans, Immunotherapy, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.